{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:40:29Z","timestamp":1791855629978,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,27]]},"DOI":"10.7759\/cureus.46075","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:55:28Z","timestamp":1695833728000},"source":"Crossref","is-referenced-by-count":3,"title":["Phenytoin-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap in Focus: A Case Report"],"prefix":"10.7759","author":[{"given":"Piyush","family":"Puri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid M","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Komal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Prachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princy","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshit","family":"Chitkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418758989","article-title":"Pediatric Stevens-Johnson syndrome\/toxic epidermal necrolysis halted by etanercept","volume":"22","author":"Gavigan GM","year":"2018","unstructured":"Gavigan GM, Kanigsberg ND, Ramien ML. Pediatric Stevens-Johnson syndrome\/toxic epidermal necrolysis halted by etanercept. J Cutan Med Surg. 2018, 22:514-5. 10.1177\/1203475418758989","journal-title":"J Cutan Med Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2020.02.003","article-title":"SJS\/TEN 2019: from science to translation","volume":"98","author":"Chang WC","year":"2020","unstructured":"Chang WC, Abe R, Anderson P, et al.. SJS\/TEN 2019: from science to translation. J Dermatol Sci. 2020, 98:2-12. 10.1016\/j.jdermsci.2020.02.003","journal-title":"J Dermatol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.964062","article-title":"Toxic epidermal necrolysis in hepatitis A infection with acute-on-chronic liver failure: case report and literature review","volume":"9","author":"Zang X","year":"2022","unstructured":"Zang X, Chen S, Zhang L, Zhai Y. Toxic epidermal necrolysis in hepatitis A infection with acute-on-chronic liver failure: case report and literature review. Front Med (Lausanne). 2022, 9:964062. 10.3389\/fmed.2022.964062","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.81865","article-title":"Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study","volume":"57","author":"Barvaliya M","year":"2011","unstructured":"Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H, Tripathi C. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. J Postgrad Med. 2011, 57:115-9. 10.4103\/0022-3859.81865","journal-title":"J Postgrad Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.148","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis; extensive review of reports of drug-induced etiologies, and possible therapeutic modalities","volume":"6","author":"Fakoya AO","year":"2018","unstructured":"Fakoya AO, Omenyi P, Anthony P, Anthony F, Etti P, Otohinoyi DA, Olunu E. Stevens-Johnson syndrome and toxic epidermal necrolysis; extensive review of reports of drug-induced etiologies, and possible therapeutic modalities. Open Access Maced J Med Sci. 2018, 6:730-8. 10.3889\/oamjms.2018.148","journal-title":"Open Access Maced J Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5530\/ijopp.13.4.64","article-title":"Phenytoin induced Steven Johnson syndrome: a case report","volume":"13","author":"Inamdar SZ","year":"2020","unstructured":"Inamdar SZ, Chirasani S, Janagond A, et al.. Phenytoin induced Steven Johnson syndrome: a case report. Indian J Phar Pract. 2020, 13:373-6. 10.5530\/ijopp.13.4.64","journal-title":"Indian J Phar Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20180676","article-title":"Phenytoin induced Stevens-Johnson syndrome: a case report","volume":"7","author":"Kulkarni S","year":"2018","unstructured":"Kulkarni S, Dattatri AN. Phenytoin induced Stevens-Johnson syndrome: a case report. Int J Basic Clin Pharmacol. 2018, 7:573-6. 10.18203\/2319-2003.ijbcp20180676","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2011.01.005","article-title":"Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases","volume":"20","author":"Hu FY","year":"2011","unstructured":"Hu FY, Wu XT, An DM, Yan B, Stefan H, Zhou D. Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases. Seizure. 2011, 20:431-2. 10.1016\/j.seizure.2011.01.005","journal-title":"Seizure"},{"key":"ref9","article-title":"Severe desquamating disorder after liver transplant: toxic epidermal necrolysis or graft versus host disease?","volume":"5","author":"Schulz JT II","year":"2006","unstructured":"Schulz JT II, Sheridan RL. Severe desquamating disorder after liver transplant: toxic epidermal necrolysis or graft versus host disease?. J Burns Wounds. 2006, 5:e1.","journal-title":"J Burns Wounds"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701753664","article-title":"Stevens-Johnson syndrome: pathogenesis, diagnosis, and management","volume":"40","author":"Hazin R","year":"2008","unstructured":"Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Med. 2008, 40:129-38. 10.1080\/07853890701753664","journal-title":"Ann Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz R","year":"2021","unstructured":"Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina (Kaunas). 2021, 57:895. 10.3390\/medicina57090895","journal-title":"Medicina (Kaunas)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.034","article-title":"Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"137","author":"Su SC","year":"2017","unstructured":"Su SC, Mockenhaupt M, Wolkenstein P, et al.. Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Invest Dermatol. 2017, 137:1065-73. 10.1016\/j.jid.2016.11.034","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620950831","article-title":"The role of IL-13, IL-15 and granulysin in the pathogenesis of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"27","author":"Sadek M","year":"2021","unstructured":"Sadek M, Iqbal O, Siddiqui F, et al.. The role of IL-13, IL-15 and granulysin in the pathogenesis of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Clin Appl Thromb Hemost. 2021, 27:1076029620950831. 10.1177\/1076029620950831","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.31080\/ASMS.2020.04.0740","article-title":"Ophthalmic manifestations and type 4 of hypersensitivity of Steven Johnson syndrome-toxic epidermal necrosis in infants-management and literature review","volume":"4","author":"Juna Musa","year":"2020","unstructured":"Juna Musa, Blina Abdullahu, Ali Guy, et al.. Ophthalmic manifestations and type 4 of hypersensitivity of Steven Johnson syndrome-toxic epidermal necrosis in infants-management and literature review. Acta Sci Pharm Sci. 2020, 4:50-3. 10.31080\/ASMS.2020.04.0740","journal-title":"Acta Sci Pharm Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu DY","year":"2016","unstructured":"Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016, 136:1387-97. 10.1016\/j.jid.2016.03.023","journal-title":"J Invest Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0530-y","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures","volume":"34","author":"Schneider JA","year":"2017","unstructured":"Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther. 2017, 34:1235-44. 10.1007\/s12325-017-0530-y","journal-title":"Adv Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1740591","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies","volume":"16","author":"Lin CC","year":"2020","unstructured":"Lin CC, Chen CB, Wang CW, Hung SI, Chung WH. Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies. Expert Rev Clin Immunol. 2020, 16:373-87. 10.1080\/1744666X.2020.1740591","journal-title":"Expert Rev Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1203475419861078","article-title":"Pediatric SJS\/TEN subdued by a combination of dexamethasone, cyclosporine, and etanercept","volume":"23","author":"Coulombe J","year":"2019","unstructured":"Coulombe J, Belzile E, Duhamel A, Rault P, Buteau C, DeBruycker JJ, Bussi\u00e8res JF. Pediatric SJS\/TEN subdued by a combination of dexamethasone, cyclosporine, and etanercept. J Cutan Med Surg. 2019, 23:547-50. 10.1177\/1203475419861078","journal-title":"J Cutan Med Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72495-phenytoin-associated-stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-overlap-in-focus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:22Z","timestamp":1707509242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72495-phenytoin-associated-stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-overlap-in-focus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.46075","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}